BACKGROUND: West Nile virus (WNV) is an emerging cause of meningitis and encephalitis in the United States. Although severe neuroinvasive disease and death can occur in rare instances, the majority of infected individuals remain asymptomatic or present with a range of clinical manifestations associated with West Nile fever. METHODS: To better understand the interindividual variability associated with the majority of WNV infections, we evaluated the association of cytokine/chemokine production and outcome of infection among 115 WNV-positive US blood donors identified in 2008-2011. All subjects self-reported symptoms as having occurred during the 2 weeks following blood donation, using a standardized questionnaire. RESULTS: We discovered that, prior to seroconversion, an early potent, largely type I interferon-mediated response correlated with development of a greater number of symptoms in WNV-infected individuals. Interestingly, individuals who developed fewer symptoms had not only a more modest type I interferon response initially, but also a protracted cytokine response after seroconversion, marked by the production of monocyte and T-cell-associated chemokines. CONCLUSIONS: Collectively, our data suggest that, although an early type I interferon response appears to be crucial to control WNV infection, successful immunity may require a modest early response that is maintained during the course of infection.
BACKGROUND:West Nile virus (WNV) is an emerging cause of meningitis and encephalitis in the United States. Although severe neuroinvasive disease and death can occur in rare instances, the majority of infected individuals remain asymptomatic or present with a range of clinical manifestations associated with West Nile fever. METHODS: To better understand the interindividual variability associated with the majority of WNV infections, we evaluated the association of cytokine/chemokine production and outcome of infection among 115 WNV-positive US blood donors identified in 2008-2011. All subjects self-reported symptoms as having occurred during the 2 weeks following blood donation, using a standardized questionnaire. RESULTS: We discovered that, prior to seroconversion, an early potent, largely type I interferon-mediated response correlated with development of a greater number of symptoms in WNV-infected individuals. Interestingly, individuals who developed fewer symptoms had not only a more modest type I interferon response initially, but also a protracted cytokine response after seroconversion, marked by the production of monocyte and T-cell-associated chemokines. CONCLUSIONS: Collectively, our data suggest that, although an early type I interferon response appears to be crucial to control WNV infection, successful immunity may require a modest early response that is maintained during the course of infection.
Authors: Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks Journal: Science Date: 2013-04-12 Impact factor: 47.728
Authors: John R Teijaro; Cherie Ng; Andrew M Lee; Brian M Sullivan; Kathleen C F Sheehan; Megan Welch; Robert D Schreiber; Juan Carlos de la Torre; Michael B A Oldstone Journal: Science Date: 2013-04-12 Impact factor: 47.728
Authors: Hilario J Ramos; Marion C Lanteri; Gabriele Blahnik; Amina Negash; Mehul S Suthar; Margaret M Brassil; Khushbu Sodhi; Piper M Treuting; Michael P Busch; Philip J Norris; Michael Gale Journal: PLoS Pathog Date: 2012-11-29 Impact factor: 6.823
Authors: Kevin W Hoffman; Jakleen J Lee; Gregory A Foster; David Krysztof; Susan L Stramer; Jean K Lim Journal: Pathog Dis Date: 2019-03-01 Impact factor: 3.166
Authors: William C Weldon; Kun Zhao; Heather A Jost; Kimbell Hetzler; Jessica Ciomperlik-Patton; Jennifer L Konopka-Anstadt; M Steven Oberste Journal: J Clin Virol Date: 2020-08-18 Impact factor: 14.481
Authors: Marija Santini; Sara Haberle; Snježana Židovec-Lepej; Vladimir Savić; Marija Kusulja; Neven Papić; Klaudija Višković; Ivana Župetić; Giovanni Savini; Ljubo Barbić; Irena Tabain; Marko Kutleša; Vladimir Krajinović; Tanja Potočnik-Hunjadi; Elizabeta Dvorski; Tamara Butigan; Gordana Kolaric-Sviben; Vladimir Stevanović; Lana Gorenec; Ivana Grgić; Filip Glavač; Armin Mehmedović; Eddy Listeš; Tatjana Vilibić-Čavlek Journal: Pathogens Date: 2022-01-02